HempFusion Launches Topical CBD Pain Relief Creams and Balms

HempFusion has a brand new FDA-approved premium Full-Spectrum hemp extract OTC line of topicals that contain ingredients scientifically proven to target relief. These ingredients are salicylic acid, colloidal oatmeal and menthol. They can provide relief for pain, eczema, acne and other afflictions.

HempFusion Full-Spectrum CBD Extract

HempFusion’s topicals also contain essential aloe vera, jojoba and shea butter oil. Besides, they feature a full-spectrum CBD extract and many other cannabinoids that naturally occur in the hemp plant, such as terpenes. Terpenes are known to work greatly for the skin because they have moisturizing and conditioning effects, not to mention they do well against pain too. Here’s what Jason Mitchell, Hemp Fusion’s co-CEO, had to say about the new launch:

“With the launch of our innovative O-T-C Topicals line, HempFusion provides consumers with high quality O-T-C products that are backed by science. By producing and marketing these products in accordance with the FDA’s O-T-C regulations, we are able to utilize active ingredients that target specific conditions for a variety of consumer needs, which we believe has the ability to substantially increase our customer base.”

Creams, Gels and Balms

The new topical line of products is available at the company’s official website. It includes a wide selection of balms and creams, a gel and an ointment included. These products are: a pain relief cream together with a balm, a pain relief cream and a balm for sports injuries, an Arnica Extract pain relief gel. When it comes to the skin formulas, these include an acne relief cream, an eczema relief one and a first aid ointment with antibiotic for wounds. The other co-CEO of HempFusion, Ian deQuieroz, had this to say about the products:

“We believe these new product offerings will increase our customer base by providing concerned retailers with the ability to stock our O-T-C Topicals with confidence that these products follow the FDA’s OTC guidelines.”